Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 191-194

  Sposito, Andrei C ^a   Carvalho, Luiz Sergio F ^a   Cintra, Riobaldo M R ^a   Araújo, Ana Laura R ^a   Ono, Andre H ^a   Andrade, Joalbo M ^a   Coelho, Otavio Rizzi ^c   Quinaglia e Silva, Jose C ^a,b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Inflammation; Myocardial infarction; Rebound effect; Statins

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT RESPONSE;

AGED; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SIMVASTATIN; TIME FACTORS; UP-REGULATION;

EID: 70350572370     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.008     Document Type: Article

References (22)

1. Spencer F.A., Allegrone J., Goldberg R.J., et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 140 (2004) 857-866
2. Spencer F.A., Fonarow G.C., Frederick P.D., et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med 164 (2004) 2162-2168
3. Sposito A.C., and Chapman M.J. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler Thromb Vasc Biol 22 (2002) 1524-1534
4. Li J.J., Li Y.S., Chen J., and Yang J.Q. Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Med Hypotheses 66 (2006) 1199-1204
5. Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
6. Pietila K., Harmoinen A., Hermens W., Simoons M.L., Van de Werf F., and Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 14 (1993) 915-919
7. Pietila K.O., Harmoinen A.P., Jokiniitty J., and Pasternack A.I. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17 (1996) 1345-1349
8. Rochitte C.E., Oliveira P.F., Andrade J.M., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 46 (2005) 1553-1558
9. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
10. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
11. Huang C.Y., Wu T.C., Lin W.T., et al. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients. Eur J Clin Invest 36 (2006) 76-84
12. Lai W.T., Lee K.T., Chu C.S., et al. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation. Int J Cardiol 98 (2005) 459-464
13. Lee K.T., Lai W.T., Chu C.S., et al. Effect of withdrawal of statin on C-reactive protein. Cardiology 102 (2004) 166-170
14. Li J.J., Li Y.S., Chu J.M., et al. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clin Chim Acta 366 (2006) 269-273
15. Vecchione C., and Brandes R.P. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 91 (2002) 173-179
16. Gertz K., Laufs U., Lindauer U., et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34 (2003) 551-557
17. Laufs U., Endres M., Custodis F., et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102 (2000) 3104-3110
18. Endres M., and Laufs U. Discontinuation of statin treatment in stroke patients. Stroke 37 (2006) 2640-2643
19. Brandes R.P., Beer S., Ha T., and Busse R. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23 (2003) 1794-1800
20. Weitz-Schmidt G. Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance. Endothelium 10 (2003) 43-47
21. Holm T., Andreassen A.K., Ueland T., et al. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol 87 (2001) 815-818 A819
22. Weis M., Pehlivanli S., Meiser B.M., and von Scheidt W. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J Am Coll Cardiol 38 (2001) 814-818